<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Public Health and Primary Care</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/62B8C8FA-41ED-4A41-99E2-B2C497897EA2"><gtr:id>62B8C8FA-41ED-4A41-99E2-B2C497897EA2</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Eborall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ES%2FE004164%2F1"><gtr:id>2D85CA2F-446A-4179-A646-CA6BA4C953BC</gtr:id><gtr:title>Lay attitudes towards risk in the context of screening, prevention and trial participation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>ES/E004164/1</gtr:grantReference><gtr:abstractText>&lt;p>This two-year post-doctoral fellowship extends doctoral research on public attitudes towards screening for cardiovascular risk, prevention of cardiovascular disease (in particular aspirin as a preventive medication), and participation in a preventive randomised control trial (RCT). &lt;/p> 
&lt;p>The doctoral research comprised qualitative interviews and focus groups with members of a healthy population invited to attend screening for asymptomatic atherosclerosis (a predictor of future cardiovascular disease), some of whom were subsequently invited to participate in an RCT assessing the effectiveness of aspirin in preventing cardiovascular events. The study sample included, unusually, those who were ineligible and those who had declined to participate in the trial.&lt;/p> 
&lt;p>Further research (post-doctoral) was nested within a primary care based screening programme for Type II Diabetes.&lt;/p> 
&lt;p>The aims of the fellowship are to:&lt;/p> 
&lt;ul> 
 &lt;li>Publish and disseminate doctoral findings to medical and social science audiences.&lt;/li> 
 &lt;li>Undertake cross-disease comparative research about lay perceptions of screening and prevention alongside large rigorous RCTs using data generated through the doctoral and post-doctoral research.&lt;/li> 
 &lt;li>Develop work on integrating data generated through mixed methods.&lt;/li> 
 &lt;li>Design future research proposals, informed by findings, for qualitative investigations nested within clinical trials, for example the impact of diagnoses of ?risk? versus diagnoses of ?disease?.&lt;/li>
&lt;/ul></gtr:abstractText><gtr:fund><gtr:end>2008-10-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2006-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>120172</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>In addition to the findings feeding into contemporary debates about screening in primary care (see 'key findings' section), the findings have been and continue to be used in various teaching settings at different institutions for example in masters in health psychology and MSc diabetes - the students on the latter being predominantly practitioners, a high proportion of whom are international). 
The findings related to preventive medicine were presented at a dissemination event organised by the NIHR CLAHRC (Birmingham &amp;amp; Black Country): 'Using sociology to help prevent cardiovascular disease' - an event focused on linking sociological work in the area to the application of it in practice.</gtr:description><gtr:firstYearOfImpact>2008</gtr:firstYearOfImpact><gtr:id>59206A87-BF4A-4DC4-A807-6FB18576DD07</gtr:id><gtr:impactTypes/><gtr:outcomeId>54632e03196723.27416534</gtr:outcomeId><gtr:sector>Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This award was a postdoctoral fellowship award to extend, further-develop, publish and disseminate my doctoral research (on public attitudes towards the screening and prevention of cardiovascular disease in a public health setting, and participation in preventive randomised control trial) and postdoctoral research (on the impact and experiences of screening for type 2 diabetes in primary care). 

The fellowship involved writing papers for publication in scientific journals and giving presentations on findings at invited seminars and academic conferences. 

Briefly, the publications on screening for type 2 diabetes concluded that a stepwise approach to such screening in primary care had limited psychological impact in the people invited. A publication exploring people's views of aspirin as a preventive medication for cardiovascular disease revealed the moral dilemmas raised and demonstrated different ways in which people attempted to resolve these through the decisions they made. A publication exploring the views of people invited to participate in a randomised controlled trial outlined explanations for declining and stopping participation: including perceptions of necessity and risk.</gtr:description><gtr:exploitationPathways>The findings have been taken forward since the end of this award (2008) by feeding into subsequent research projects and contemporary debate. For example, the publications related to the experiences and impact of screening made a significant contribution to the debate about psyhological harms and benefits of screening for type 2 diabetes in primary care - which has been relevant due to the subsequent introduction of the NHS Healthchecks. The two publications in the BMJ continue to be accessed over 7 years after publication and have both been widely cited.</gtr:exploitationPathways><gtr:id>6EB864BA-183D-411A-B12E-8C79848A21A3</gtr:id><gtr:outcomeId>546206c15637a1.19573493</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BC949E10-135E-4C5A-9234-BFBF782C8688</gtr:id><gtr:title>Patients' experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae5f24a017f34f149566b9176a401ae6"><gtr:id>ae5f24a017f34f149566b9176a401ae6</gtr:id><gtr:otherNames>Eborall H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5461fe10920210.97840551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4D11ED5-B367-4730-94F6-DC1EE95E5997</gtr:id><gtr:title>Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cbce69228eacca697e0f0e726646e7b"><gtr:id>5cbce69228eacca697e0f0e726646e7b</gtr:id><gtr:otherNames>Eborall HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5461fe106bb353.27445289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDA84E58-6C28-47A4-BAC1-8E998E955C91</gtr:id><gtr:title>&amp;acirc;??Prevention is better than cure, but &amp;acirc;?&amp;brvbar;&amp;acirc;??: Preventive medication as a risk to ordinariness?</gtr:title><gtr:parentPublicationTitle>Health, Risk &amp; Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae5f24a017f34f149566b9176a401ae6"><gtr:id>ae5f24a017f34f149566b9176a401ae6</gtr:id><gtr:otherNames>Eborall H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>5461fd1c1887b6.10001618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E95A54B4-F4D1-48D9-B10F-285121592943</gtr:id><gtr:title>Accrual and drop out in a primary prevention randomised controlled trial: qualitative study.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cbce69228eacca697e0f0e726646e7b"><gtr:id>5cbce69228eacca697e0f0e726646e7b</gtr:id><gtr:otherNames>Eborall HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5461fd1c40afa7.05860439</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">ES/E004164/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>5858EC49-4786-4440-8352-1AB0B6DC5F23</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Psychology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>5858EC49-4786-4440-8352-1AB0B6DC5F23</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Psychology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>